The Mercia Technology Seed Fund has a growing portfolio of venture capital investments in early-stage, technology-based companies located in the West Midlands. These investments have focused on companies operating across five key technology sectors:
 

Medical Healthcare Technologies

• Anaxsys Technology Ltd: Development of products for monitoring and diagnosis of asthma, COPD, and sleep apnoea.
• Celentyx Ltd: Pharmaceutical re-profiling and development systems.
• Hybrid Systems Ltd: Proprietary technology with applications in oncology and immunology.
• Intelligent Orthopaedics Ltd: Development of products for treating orthopaedic trauma.
• Nanotherics Ltd: Development of scientific and medical devices.
• Nightingale EOSLtd: Development of laser based technology for use in medical use
• Sarissa Biomedical Ltd: Development and production of biosensors with medical diagnostic applications.
• Warwick Effect Polymers Ltd: Proprietary polymer synthesis with industrial and pharmaceutical applications.

Advanced Materials

• Warwick Audio Technologie Ltd: Development of ultra-thin, lightweight mid-range loud speakers.

Environmental

• Circadian Solar Ltd: Design and development of concentrator photovoltaic systems.

ICT

• Allinea Ltd: Development of software tools for parallel computing systems
• Concurrent Thinking Ltd: Design and development of integrated High Performance Computing clusters.
• DigePrint Ltd: Design and production of commercial digital printing systems.
• LM Technologies Ltd: Design and development of wireless communication products.
• Optical Antenna Solutions Ltd: Proprietary technology for use in optical communications research and development.
• Scyron Ltd: Video analytics technology with defence and public safety applications.